Wikidata

(Q64651252)

English

Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry

clinical trial

In more languages

Statements

short name
SABLE (English)
0 references
title
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab) (English)
0 references
country
Argentina
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
France
0 references
Germany
0 references
Israel
0 references
Italy
0 references
Portugal
0 references
Slovakia
0 references
Spain
0 references
Sweden
0 references
start time
21 February 2013
0 references
end time
31 January 2025
0 references
number of participants
3,000
0 references
research site
GSK
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64651252&oldid=1857869067"